The first batch of CoronaVac vaccine manufactured by the Sinovac Biotech Chinese company has been sent to Ukraine.
Thanks to the persistent efforts of the Embassy, the first batch of 1.915 million CoronaVac vaccine doses produced by the Sinovac Biotech Chinese company was sent to Ukraine on March 25.

The inactivated vaccine, which was registered by the Ministry of Health of Ukraine on March 10, passed all stages of clinical trials, officially confirming its efficacy and safety and is now widely used to protect the population from pandemics in China, Brazil, Mexico, Chile, Turkey, Indonesia, Thailand, Malaysia and other countries.

Sinovac Biotech was founded in 1999 and is currently a world leader in the creation and production of vaccines of various types (hepatitis A and B, chickenpox, bird flu H5N1, swine flu H1N1, enteroviruses, etc.).